Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure With A Preserved Ejection Fraction Associated With Coronary Microvascular Dysfunction

NCT07057323 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07057323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07057323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure With A Preserved Ejection Fraction Associated With Coronary Microvascular Dysfunction
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
October 16, 2025
Completion date
August 31, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure preserved ejection fraction